Early irradiation with radiochemotherapy for limited-stage small cell lung cancer is superior to late irradiation;Die frühzeitige radiotherapie im rahmen der radiochemotherapie des kleinzelligen bronchialkarzinoms ist im stadium "limited disease" der späteren bestrahlung überlegen

Strahlentherapie und Onkologie

Volumn 178, Issue 11, 2002, Pages 585-588

  Fietkau, Rainer ^a   Sauer, Rolf ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; VINCRISTINE;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CLINICAL TRIAL; EDITORIAL; HUMAN; LEUKOPENIA; LUNG SMALL CELL CANCER; PROGNOSIS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SMALL CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS; SURVIVAL RATE;

EID: 0036855177     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (11)

1. Gregor A, Drings P, Burghouts J, et al. Randomized trial of alternating versus sequential radiotherapy/hemotherapy in limited-disease patients with small-cell lung cancer: A European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group Study. J Clin Oncol 1997; 15:2840-9.
2. Jeremic B, Shibamoto Y, Acimovic L, et al. Initial versus delayed acceterated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: A randomized study. J Clin Oncol 1997:15:893-900.
3. Machtay M, et al. The early rad catches the tumor? J Clin Oncol 2002:20:3045-7.
4. Murray N, Coy P, Pater JL, et al. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. J Clin Oncol 1993;11:336-44.
5. Perry MC, Eaton WL, Propert KJ, et al. Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung. N Engl J Med 1987;316:912-8.
6. Pignon JP, Arriagada R, Ihde DC, et al. A meta-analysis of thoracic radiotherapy for small cell lung cancer. N Engl J Med 1992;327:1618-24.
7. Skarlos DV, Samantas E, Briassoulis E, et al. Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: A randomized phase II study of the hellenic cooperative oncology group (HeCOG). Ann Oncol 2001;12:1231-8.
8. Takada M, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: Results of the Japan clinical oncology group study 9104. J Clin Oncol 2002:20:3054-64.
9. Turissi AT, Kim K, Blum R, et al. Twice-daily compared with once-daily thoracic radiotherapy in limited smatt-cell lung cancer treated concurrently with cisplatin and etooposide. N Engl J Med 1999;340:265-71.
10. Warde P, Payne D. Does thoracic irradiation improve survival and local control in limited stage small cell carcinoma of the lung? A meta-analysis. J Clin Oncol 1992;6:890-5.
11. Work, E, Nielsen OS, Bentzen SM, et al. Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer. J Clin Oncol 1997;15:3030-7.